Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5208857
Max Phase: Preclinical
Molecular Formula: C27H37N3O3
Molecular Weight: 451.61
Associated Items:
ID: ALA5208857
Max Phase: Preclinical
Molecular Formula: C27H37N3O3
Molecular Weight: 451.61
Associated Items:
Canonical SMILES: [2H]C12CC3CC(NC(=O)NC4CCN(C(=O)C5CCOCC5)CC4)(CC(C1)c1ccccc13)C2
Standard InChI: InChI=1S/C27H37N3O3/c31-25(19-7-11-33-12-8-19)30-9-5-22(6-10-30)28-26(32)29-27-15-18-13-20(16-27)23-3-1-2-4-24(23)21(14-18)17-27/h1-4,18-22H,5-17H2,(H2,28,29,32)/i18D
Standard InChI Key: KFEQITVWRPLSPF-VAAKKRCDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 451.61 | Molecular Weight (Monoisotopic): 451.2835 | AlogP: 3.92 | #Rotatable Bonds: 3 |
Polar Surface Area: 70.67 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.42 | CX LogP: 2.05 | CX LogD: 2.05 |
Aromatic Rings: 1 | Heavy Atoms: 33 | QED Weighted: 0.73 | Np Likeness Score: -1.01 |
1. Codony S, Entrena JM, Calvó-Tusell C, Jora B, González-Cano R, Osuna S, Corpas R, Morisseau C, Pérez B, Barniol-Xicota M, Griñán-Ferré C, Pérez C, Rodríguez-Franco MI, Martínez AL, Loza MI, Pallàs M, Verhelst SHL, Sanfeliu C, Feixas F, Hammock BD, Brea J, Cobos EJ, Vázquez S.. (2022) Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors., 65 (20.0): [PMID:36222708] [10.1021/acs.jmedchem.2c00515] |
Source(1):